| abstract |
The present invention provides a small compound that targets at TACC3. The present invention also provides a medicinal agent, particularly an anti-cancer agent, which comprises a small compound that targets at TACC3.nA compound represented by general formula (I), or a pharmaceutically acceptable salt, a solvate or an ester derivative of the compound can bind to TACC3 to inhibit the proliferation of cells. Therefore, each of these compounds can be used as a medicinal agent, particularly an anti-cancer agent. |